A Phase III Placebo-Controlled Trial Of Celecoxib In Genotype Positive Subjects With Familial Adenomatous Polyposis.

Trial Profile

A Phase III Placebo-Controlled Trial Of Celecoxib In Genotype Positive Subjects With Familial Adenomatous Polyposis.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 11 Aug 2017

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Colorectal cancer; Familial adenomatous polyposis
  • Focus Registrational; Therapeutic Use
  • Acronyms CHIP
  • Sponsors Pfizer
  • Most Recent Events

    • 09 Feb 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 09 Feb 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 09 Feb 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top